Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/29/2025

Iron Deficiency Anemia Treatment Guidelines

Dosing Recommendations

  • For mild iron deficiency anemia, the recommended dose of ferrous sulphate is 60-100 mg of elemental iron once daily, which is equivalent to approximately 200-300 mg of ferrous sulphate per day, as recommended by the Centers for Disease Control and Prevention 1, 2
  • Pregnant women should take 60-120 mg elemental iron daily, equivalent to 200-300 mg ferrous sulphate, according to the Centers for Disease Control and Prevention 1, 3
  • Women with heavy menstrual bleeding may require higher doses of 50-100 mg elemental iron daily, as suggested by the World Health Organization 4
  • Patients with inflammatory bowel disease should not take more than 100 mg elemental iron per day, as recommended by the European Crohn's and Colitis Organisation 5, 6

Administration Guidelines

  • Iron supplements should be taken on an empty stomach, 1 hour before or 2 hours after meals, to optimize absorption, as recommended by the European Society for Clinical Nutrition and Metabolism 2
  • Taking iron supplements with vitamin C or citrus juice can enhance absorption, according to the National Institutes of Health 4
  • Avoid taking iron supplements with calcium supplements, dairy products, tea, coffee, or antacids, as they can reduce absorption, as recommended by the European Society for Clinical Nutrition and Metabolism 2, 4
  • Separate iron and calcium supplements by 1-2 hours, as suggested by the National Institutes of Health 4

Duration of Treatment

  • Treatment should continue for 3 months after hemoglobin normalizes to replenish iron stores, as recommended by the European Society for Clinical Nutrition and Metabolism 2
  • For women with confirmed iron deficiency anemia, iron treatment should continue for 2-3 months after normalization of hemoglobin, according to the Centers for Disease Control and Prevention 1, 7

Monitoring Response

  • Expect hemoglobin to rise by approximately 1 g/dL after 4 weeks of therapy, as recommended by the Centers for Disease Control and Prevention 1, 3
  • If no response after 4 weeks despite compliance, further evaluation is needed, according to the Centers for Disease Control and Prevention 1, 3
  • Monitor hemoglobin and red cell indices at 3-month intervals for the first year after correction, then annually, as recommended by the European Crohn's and Colitis Organisation 5, 2

Common Side Effects and Management

  • Gastrointestinal side effects include nausea, constipation, abdominal discomfort, and dark stools, as reported by the European Society for Clinical Nutrition and Metabolism 2
  • Side effects are dose-dependent; lower doses may be better tolerated, according to the European Crohn's and Colitis Organisation 5
  • If side effects occur, consider taking with food, although this may reduce absorption by 40-50%, as recommended by the European Society for Clinical Nutrition and Metabolism 2
  • Consider switching to a different iron formulation, such as ferrous gluconate or ferrous fumarate, as suggested by the European Crohn's and Colitis Organisation 5, 8

When to Consider Alternative Approaches

  • Consider intravenous iron if oral iron is not tolerated, as recommended by the European Crohn's and Colitis Organisation 6
  • Consider intravenous iron if the patient has malabsorption issues, as suggested by the American Gastroenterological Association 8
  • Consider intravenous iron if there is no response to oral iron therapy after 4 weeks, according to the European Society for Clinical Nutrition and Metabolism 2, 6
  • Consider intravenous iron if the patient has severe anemia, as recommended by the European Crohn's and Colitis Organisation 6